The Ocella birth control pill, marketed by Barr Laboratories, Inc. is the generic version of YAZ or Yasmin that has been linked to a number of serious, life-threatening side effects including but not limited to heart attack, stroke, DVT, pulmonary embolism, blood clots, abnormal heart rhythm, gall bladder injury, pancreatitis and death.
Ocella Update 6/26/12: A new study has found that a widely prescribed class of contraceptive products containing a synthetic hormone known as drospirenone may increase the risk for irritable bowel syndrome (IBS), a chronic condition that involves symptoms such as severe abdominal pain, discomfort, bloating, and altered bowel habits. The researchers found that women were almost twice as likely to be diagnosed with IBS after initiating a regimen of drospirenone-based birth control pills than women who took products containing levonorgestrel, a ‘third generation’ progestin found in many older types of contraceptives.
Ocella Blood Clot Lawsuit Update 4/13/12: Pharmaceutical giant Bayer will pay at least $110 million to settle approximately 500 lawsuits over claims that its controversial line of Yasmin birth control products cause blood clots. Officials of Germany’s largest drugmaker reportedly agreed to pay an average of about $220,000 a case to resolve the complaints, people familiar with the agreements said.
Ocella Blood Clot Update 4/10/12: Birth control products containing the synthetic hormone drospirenone have been linked to an increased risk for blood clots, according to a warning issued today by the U.S. Food & Drug Administration (FDA). In response to these findings, the FDA has required that all drospirenone-containing contraceptives carry warnings which state that several studies have found as much as a three-fold increased risk of blood clots associated with drospirenone when compared to levonorgestrel, a different hormone found in many older forms of birth control.
Ocella Blood Clot Update 12/9/11: An independent advisory panel to the FDA has recommended that all birth control products containing the hormone drospirenone should have their labels updated to include warnings about blood clots. The panel’s recommendation was based on new data suggesting that the popular contraceptives may put women at a higher risk for dangerous blood clots than older forms of birth control.
BIRTH CONTROL BLOOD CLOT UPDATE: 4/25/11
Two new British Medical Journal (BMJ) studies have confirmed that Yaz, Yasmin, Ocella and other new ‘fourth generation’ birth control medications significantly increase the risk of blood clots over those taking older birth control products. The results of the studies highlight the well known fact that the mix of hormones needed to prevent pregnancy also promote clotting factors.
Free Ocella Lawsuit Evaluation: If you or a loved one suffered a blood clot after taking Ocella, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer and our lawyers can help.
What’s the problem?
Since 2004, there have been over 50 deaths reported to the U.S. Food & Drug Administration (FDA) of women who were taking YAZ, Yasmin or Ocella. Some of the deaths associated with women taking Ocella included cardiac arrhythmia, cardiac arrest, intracardiac thrombus (blood clots in the heart), pulmonary embolism (blood clot in the lungs), and stroke.
Do I Have an Ocella Lawsuit?
The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in Ocella lawsuits. We are handling individual litigation nationwide and currently accepting new blood clot cases in all 50 states.
Free Confidential Case Evaluation: Again, if you developed a blood clot after using Ocella, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and our lawyers can help.